Please provide your email address to receive an email when new articles are posted on . Risk of death from all causes was similarly lower for patients on hemodialysis prescribed either allopurinol or ...

CVD, CHD, cardiovascular disease Researchers assessed whether febuxostat increased the risk of developing cardiovascular events, death from cardiac-cause, and all-cause mortalities. Use of febuxostat ...

Among patients with hyperuricemia on hemodialysis, allopurinol significantly decreased cardiovascular risks, whereas febuxostat did not. Allopurinol and febuxostat both reduce death risk in patients ...

DASH diet may lower risk of gout. Preliminary clinical trial results show more heart-related deaths occur in patients taking febuxostat compared to allopurinol. The Food and Drug Administration (FDA) ...

The 2012 American College of Rheumatology gout treatment guidelines recommend titration of urate-lowering medication doses to achieve target serum uric acid (sUA) levels of less than 6 mg/dL. Analysis ...